TY - JOUR T1 - Prioritization of Patients for Comprehensive Medication Review By a Clinical Pharmacist in Family Medicine JF - The Journal of the American Board of Family Medicine JO - J Am Board Fam Med SP - 418 LP - 424 DO - 10.3122/jabfm.2015.03.140303 VL - 28 IS - 3 AU - Joseph P. Vande Griend AU - Joseph J. Saseen AU - Debra Bislip AU - Caroline Emsermann AU - Colleen Conry AU - Wilson D. Pace Y1 - 2015/05/01 UR - http://www.jabfm.org/content/28/3/418.abstract N2 - Background: This pilot study describes and evaluates the clinical pharmacy priority (CP2) score. We hypothesize that patients with high CP2 scores are more likely to receive a medication recommendation after comprehensive medication review (CMR) than patients with lower scores. Prioritization of patients for CMR by a clinical pharmacist in family medicine could enhance the provision of interprofessional care within the patient-centered medical home. Methods: The CP2 score was developed collaboratively by the research team and is derived from 11 patient-specific factors extracted from the electronic health record. To evaluate the utility of the score, CMR was performed prospectively by a clinical pharmacist for patients with appointments between October 1 and December 31, 2012, at 2 University of Colorado family medicine clinics. Results: CMR was performed for 1107 patient appointments. Of these, 101 were identified as having received a medication recommendation from the clinical pharmacist. For patients with a CP2 score of 0 to 2, 2 of 588 charts (0.3%) reviewed received a recommendation (level 1). The proportion increased to 37 of 358 (10.3%) for scores of 3 to 7 (level 2), 40 of 119 (33.6%) for scores of 8 to 10 (level 3), and 22 of 42 (52.4%) for scores of ≥11 (level 4). Compared with CP2 scores in level 1, patient appointments were more likely to receive a medication recommendation after CMR in level 2 (relative risk [RR], 30.4; 95% confidence interval [CI], 7.4–125.3), in level 3 (RR, 98.8; 95% CI, 24.2–403.3), and in level 4 (RR, 154; 95% CI, 37.5–632.8). Conclusions: Patients with higher CP2 scores were more likely to receive a medication recommendation after CMR by a clinical pharmacist than patients with lower scores. The CP2 score could be used by clinical pharmacists in family medicine to enhance the efficient and effective delivery of interprofessional care. ER -